-
1.
公开(公告)号:US20130023497A1
公开(公告)日:2013-01-24
申请号:US13376956
申请日:2010-06-07
Applicant: Chunlin Tao , Qinwei Wang , Tulay Polat , Laxman Nallan , Neil Desai
Inventor: Chunlin Tao , Qinwei Wang , Tulay Polat , Laxman Nallan , Neil Desai
IPC: C07D401/14 , C07D413/14 , C07D417/14 , C07D409/14 , C07D403/14 , C07D487/14 , C07D487/04 , A61K31/53 , A61K31/5377 , A61K31/655 , A61K31/635 , A61K31/538 , A61K31/541 , A61P35/00 , A61P43/00 , A61P9/00 , A61P19/02 , A61P9/10 , A61P37/00 , A61P27/02 , A61P37/06 , A61P29/00 , A61P17/02 , A61P11/00 , A61P31/00 , C07D401/12
CPC classification number: C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14
Abstract: The present invention comprises inter alia triazine compounds as shown in formula (I) and pharmaceutically acceptable salts thereof.
Abstract translation: 本发明尤其包括式(I)所示的三嗪化合物及其药学上可接受的盐。
-
公开(公告)号:US09078902B2
公开(公告)日:2015-07-14
申请号:US13376814
申请日:2010-06-09
Applicant: Chunlin Tao , Qinwei Wang , Laxman Nallan , Tulay Polat , David Ho , Neil Desai
Inventor: Chunlin Tao , Qinwei Wang , Laxman Nallan , Tulay Polat , David Ho , Neil Desai
IPC: C07D403/14 , C07D405/14 , C07D409/14 , A61K31/496 , A61K31/53 , C07D403/12 , C07D417/12 , C07D417/14 , A61P35/00 , C07D401/14
CPC classification number: A61K31/53 , A61K31/496 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D417/12 , C07D417/14
Abstract: The invention provides Triazine derivatives and further provides methods of using these compounds to modulate protein kinases and for treating diseases and conditions mediated by protein kinases.
Abstract translation: 本发明提供三嗪衍生物,并进一步提供使用这些化合物调节蛋白激酶和治疗由蛋白激酶介导的疾病和病症的方法。
-
3.Benzyl substituted triazine derivatives and their therapeutical applications 有权
Title translation: 苄基取代的三嗪衍生物及其治疗应用公开(公告)号:US08877924B2
公开(公告)日:2014-11-04
申请号:US13377031
申请日:2010-06-08
Applicant: Chunlin Tao , Qinwei Wang , David Ho , Laxman Nallan , Tulay Polat , Xiaowen Sun , Neil Desai
Inventor: Chunlin Tao , Qinwei Wang , David Ho , Laxman Nallan , Tulay Polat , Xiaowen Sun , Neil Desai
IPC: C07D403/04 , C07D403/12 , C07D403/14 , C07D417/12 , C07D417/14 , C07D413/14 , C07D409/14 , C07D405/14
CPC classification number: C07D417/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/12
Abstract: The invention provides triazine compounds and methods of their use to modulate protein kinases and to treat diseases mediated by said protein kinases.
Abstract translation: 本发明提供了三嗪化合物及其用于调节蛋白激酶和治疗由所述蛋白激酶介导的疾病的方法。
-
4.UREIDOPHENYL SUBSTITUTED TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS 审中-公开
Title translation: UREIDOPHENYL替代TRIAZINE衍生物及其治疗应用公开(公告)号:US20120202818A1
公开(公告)日:2012-08-09
申请号:US13376818
申请日:2010-06-09
Applicant: Chunlin Tao , Qinwei Wang , Lukasz Koroniak , Laxman Nallan , Neil Desai
Inventor: Chunlin Tao , Qinwei Wang , Lukasz Koroniak , Laxman Nallan , Neil Desai
IPC: A61K31/53 , C07D403/12 , C07D417/12 , A61P35/00 , A61P9/10 , A61P9/04 , A61P27/02 , A61P19/02 , A61P37/00 , A61P29/00 , A61P19/04 , A61P37/06 , A61P11/00 , A61P9/00 , C07D417/14
CPC classification number: A61K31/53 , C07D403/12 , C07D405/14 , C07D417/12 , C07D417/14
Abstract: The present invention provides Uredophenyl substituted triazine derivatives and provides methods of using these compounds to modulate protein kinases and methods of using these compounds to treat protein kinase mediated diseases and conditions.
Abstract translation: 本发明提供Uredophenyl取代的三嗪衍生物,并提供使用这些化合物调节蛋白激酶的方法和使用这些化合物治疗蛋白激酶介导的疾病和病症的方法。
-
5.TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS 审中-公开
Title translation: TRIAZINE衍生物及其治疗应用公开(公告)号:US20120172361A1
公开(公告)日:2012-07-05
申请号:US13376760
申请日:2010-06-07
Applicant: Chunlin Tao , Qinwei Wang , Tulay Polat , Laxman Nallan , David Ho , Neil Desai
Inventor: Chunlin Tao , Qinwei Wang , Tulay Polat , Laxman Nallan , David Ho , Neil Desai
IPC: A61K31/53 , C07D403/12 , C07D251/38 , C07D413/14 , A61K31/5377 , A61P11/00 , A61P9/04 , A61P9/10 , A61P19/02 , A61P29/00 , A61P37/06 , A61P17/02 , C07D403/14 , A61P35/00
CPC classification number: C07D403/12 , C07D251/28 , C07D251/38 , C07D401/12 , C07D401/14 , C07D413/12 , C07D417/04 , C07D417/14
Abstract: Compounds of the formula (I) and formula (II) and pharmaceutically acceptable salts thereof.
Abstract translation: 式(I)和式(II)的化合物及其药学上可接受的盐。
-
6.
公开(公告)号:US20120238576A1
公开(公告)日:2012-09-20
申请号:US13376964
申请日:2010-06-07
Applicant: Chunlin Tao , Qinwei Wang , Laxman Nallan , Tulay Polat , Lukasz Koroniak , Neil Desai
Inventor: Chunlin Tao , Qinwei Wang , Laxman Nallan , Tulay Polat , Lukasz Koroniak , Neil Desai
IPC: A61K31/53 , C07D417/14 , A61K31/5377 , C07D403/14 , C07D403/12 , A61P35/00 , A61P9/10 , A61P25/00 , A61P9/04 , A61P19/02 , A61P37/00 , A61P27/02 , A61P29/00 , A61P37/06 , A61P17/02 , A61P7/10 , A61P11/00 , C07D413/14 , A61P9/00 , C07D417/12
CPC classification number: A61K31/53 , A61K45/06 , A61K2300/00
Abstract: The present invention comprises inter alia compounds as shown in formula (I) or a pharmaceutically acceptable salt thereof.
Abstract translation: 本发明尤其包括式(I)所示的化合物或其药学上可接受的盐。
-
公开(公告)号:US06362331B1
公开(公告)日:2002-03-26
申请号:US09822782
申请日:2001-03-30
Applicant: Ahmed Kamal , Chakravarthy Laxman Nallan , Ramesh Gujjar , Ramulu Poddutoori , Srinivas Olepu
Inventor: Ahmed Kamal , Chakravarthy Laxman Nallan , Ramesh Gujjar , Ramulu Poddutoori , Srinivas Olepu
IPC: C07D51900
CPC classification number: C07D519/00
Abstract: The present invention provides a process for the preparation of a novel pyrrolo[2,1-c][1,4]benzodiazepine of formula VI wherein R is H, OII, OAc and R1 is H, and n is 3 to 5, by reacting (2S)-N-[4-hydroxy-5-methoxy-2-nitrobenzyl]-pyrrolidine-2-carboxy-carbaldehyde diethyl thioacetal with a dibromoalkane, isolating (2S)-N-[4-(3-bromoalkoxy)-5-methoxy-2-nitrobenzoyl]pyrrolidine-2-carboxy carbaldehyde diethyl thioacetal so formed and reacting the isolate with a dilactam, isolating 8-{[(2S)-N-5-methoxy-2-nitrobenzoyl]pyrrolidin-2-carbaldehyde diethylthioacetal}-alkoxy-7-methoxy-2,3,5,10,11,11a-hydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11 dione, reducing the above nitro compound, isolating the 8-{[(2S)-N-5-methoxy-2-aminobenzoyl]pyrrolidin-2-carbaldehyde diethylthioacetal]-alkoxy-7-methoxy-2,3,5,10,11,11a-hydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11-dione, reacting the amino compound above with a deprotecting agent to obtain the pyrrolo[2,1-c][1,4]benzodiazepines of formula VI wherein R, R1 and n are as stated above.
Abstract translation: 本发明提供制备式Ⅵ的新型吡咯并[2,1-c] [1,4]苯并二氮杂的方法,其中R为H,OII,OAc和R 1为H,n为3至5,通过反应 (2S)-N- [4-羟基-5-甲氧基-2-硝基苄基] - 吡咯烷-2-羧基 - 甲醛二乙基硫代缩醛与二溴烷烃,分离(2S)-N- [4-(3-溴烷氧基)-5 - 甲氧基-2-硝基苯甲酰基]吡咯烷-2-羧基甲醛二乙基硫代缩醛,并使分离物与二酰胺反应,分离8 - {[(2S)-N-5-甲氧基-2-硝基苯甲酰基]吡咯烷-2-甲醛二乙硫基缩醛 } - 烷氧基-7-甲氧基-2,3,5,10,11,11a-氢-1H-吡咯并[2,1-c] [1,4]苯并二氮杂-5,11-二酮,还原上述硝基化合物, 分离8 - {[(2S)-N-5-甲氧基-2-氨基苯甲酰基]吡咯烷-2-甲醛二乙硫基缩醛] - 烷氧基-7-甲氧基-2,3,5,10,11,11a-氢-1H- 吡咯并[2,1-c] [1,4]苯并二氮杂-5,11-二酮,使上述氨基化合物与脱保护剂反应,得到式VI的吡咯并[2,1-c] [1,4]苯并二氮杂 其中 R,R1和n如上所述。
-
8.BENZYL SUBSTITUTED TRIAZINE DERIVATIVES AND THEIR THERAPEUTICAL APPLICATIONS 有权
Title translation: 苄基取代的TRIAZINE衍生物及其治疗应用公开(公告)号:US20120264759A1
公开(公告)日:2012-10-18
申请号:US13377031
申请日:2010-06-08
Applicant: Chunlin Tao , Qinwei Wang , David Ho , Laxman Nallan , Tulay Polat , Xiaowen Sun , Neil Desai
Inventor: Chunlin Tao , Qinwei Wang , David Ho , Laxman Nallan , Tulay Polat , Xiaowen Sun , Neil Desai
IPC: A61K31/53 , A61P35/00 , A61P9/04 , A61P9/10 , A61P11/00 , A61P27/02 , A61P37/02 , A61P29/00 , A61P37/06 , C07D403/04 , A61P19/02
CPC classification number: C07D417/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/12
Abstract: The invention provides triazine compounds and methods of their use to modulate protein kinases and to treat diseases mediated by said protein kinases.
Abstract translation: 本发明提供了三嗪化合物及其用于调节蛋白激酶和治疗由所述蛋白激酶介导的疾病的方法。
-
公开(公告)号:US20120196860A1
公开(公告)日:2012-08-02
申请号:US13376814
申请日:2010-06-09
Applicant: Chunlin Tao , Qinwei Wang , Laxman Nallan , Tulay Polat , David Ho , Neil Desai
Inventor: Chunlin Tao , Qinwei Wang , Laxman Nallan , Tulay Polat , David Ho , Neil Desai
IPC: A61K31/5377 , C07D409/14 , A61K31/53 , C07D413/14 , C07D403/14 , C07D401/14 , A61P35/00 , A61P9/00 , A61P9/04 , A61P9/10 , A61P19/02 , A61P27/02 , A61P37/06 , A61P29/00 , A61P17/02 , A61P11/00 , C07D405/14
CPC classification number: A61K31/53 , A61K31/496 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D417/12 , C07D417/14
Abstract: The invention provides Triazine derivatives and further provides methods of using these compounds to modulate protein kinases and for treating diseases and conditions mediated by protein kinases.
Abstract translation: 本发明提供三嗪衍生物,并进一步提供使用这些化合物调节蛋白激酶和治疗由蛋白激酶介导的疾病和病症的方法。
-
-
-
-
-
-
-
-